Enabling early AAV characterization – The role of mass photometry in upstream process development

Assessing mRNA stability and integrity using mass photometry

USP AAV standards to support quality testing and characterization

Mass photometry for AAV manufacturing: Faster downstream processing

Demonstrating comparability in AAV analytical development

Assessing AAV stability with mass photometry: Striking insights into the outcomes of heated capsids

Mass photometry for AAV characterization: Ensuring GMP compliance

Advancements in Protein Design Shaping the Future of Nanodevices

Derisk early and accelerate antibody development with mass photometry

Unraveling Tau Protein Aggregation: Mass Photometry & Neurodegeneration